Loading company…
Riskpilot
← Back to search
Sign in
Get full access
RecQ Clinical Oy
OY
Active
Y-tunnus 2947643-2
Rälssintie 2
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2018
— employees
www.recq.fi
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
EUR 899K
+9% vs 2023
EBITDA margin
161.9%
+4% vs 2023
Equity ratio
81.0%
Financial strength
Net profit 2024
EUR 134K
+14% vs 2023
EBITDA — year on year
EUR millions
1M
1M
1M
0M
0M
0M
2020
0M
0%
2021
1M
+100%
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
EUR 899K
+9%
EBITDA
EUR 1,5M
+4%
Net profit
EUR 134K
+14%
Total assets
EUR 173K
-10%
Equity
EUR 140K
+14%
Employees
—
—
Company information
Legal name
RecQ Clinical Oy
Y-tunnus number
2947643-2
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19. lokakuuta 2018
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Kaikki laillinen liiketoiminta.
Contact
Address
Rälssintie 2
Phone
+3580449880232
Email
admin@recq.fi
Website
www.recq.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Helsinki
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
1M
2023
1M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
1M
2023
1M
2024
Income statement
EUR thousands
Item
2020
2021
2022
2023
2024
Revenue
256
296
567
824
899
Staff expenses
−62
−57
117
110
104
EBITDA
80
107
914
1 397
1 455
Depreciation & amort.
−16
—
—
3
5
EBIT
64
107
221
248
337
Net financials
−1
−0
−0
—
0
Profit before tax
62
107
221
248
337
Tax
13
21
31
30
33
Net profit
50
85
123
118
134
Balance sheet
EUR thousands
Item
2020
2021
2022
2023
2024
Total assets
134
108
167
192
173
Equity
60
88
126
123
140
Long-term debt
41
—
—
—
—
Short-term debt
33
20
41
69
33
Total debt
75
20
41
69
33
Financial ratios
5-year trend
EBITDA margin
161.9%
This company
15.8%
Market median
+925% vs market
2020
2024
Equity ratio
81.0%
This company
38.2%
Market median
+112% vs market
2020
2024
Return on equity
95.5%
This company
18.4%
Market median
+419% vs market
2020
2024
Net profit margin
14.9%
This company
8.1%
Market median
+84% vs market
2020
2024
Asset turnover
5.19×
This company
1.12×
Market median
+363% vs market
2020
2024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
RN
Rekavt Naderipour
Chief Executive Officer
Chief Executive Officer
2018
PJ
Pasi Juhani Tilander
Deputy Member
Deputy Member
2018
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of RecQ Clinical Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Rekavt Naderipour
Chief Executive Officer
0 companies
Pasi Juhani Tilander
Deputy Member
0 companies